These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9105765)

  • 1. Thrombotic microangiopathy in renal transplant recipients treated with cyclosporin A.
    Zent R; Katz A; Quaggin S; Cattran D; Wade J; Cardella C; Zaltzman J; Fenton S; Cole E
    Clin Nephrol; 1997 Mar; 47(3):181-6. PubMed ID: 9105765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts.
    Morozumi K; Thiel G; Albert FW; Banfi G; Gudat F; Mihatsch MJ
    Clin Nephrol; 1992 Jul; 38(1):1-8. PubMed ID: 1499163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes of acute thrombotic microangiopathy in patients receiving kidney transplantation.
    Jumani A; Hala K; Tahir S; Al-Ghamdi G; Al-Flaiw A; Hejaili F; Qureshi J; Raza H; Ghalib M; Khader AA
    Exp Clin Transplant; 2004 Dec; 2(2):268-72. PubMed ID: 15859940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
    Wiener Y; Nakhleh RE; Lee MW; Escobar FS; Venkat KK; Kupin WL; Mozes MF
    Clin Transplant; 1997 Jun; 11(3):157-62. PubMed ID: 9193835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
    Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
    Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy.
    Bren A; Pajek J; Grego K; Buturovic J; Ponikvar R; Lindic J; Knap B; Vizjak A; Ferluga D; Kandus A
    Transplant Proc; 2005 May; 37(4):1889-91. PubMed ID: 15919494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic microangiopathy in the early post-renal transplant period.
    Ardalan MR; Shoja MM; Tubbs RS; Etemadi J; Esmaili H; Khosroshahi HT
    Ren Fail; 2008; 30(2):199-203. PubMed ID: 18300121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
    Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
    Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A; Woo KT
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-induced nephrotoxicity in renal allograft recipients.
    Ahuja TS; Niaz N; Agraharkar M
    Clin Nephrol; 2000 Jul; 54(1):11-4. PubMed ID: 10939751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
    Oberbauer R; Kreis H; Johnson RW; Mota A; Claesson K; Ruiz JC; Wilczek H; Jamieson N; Henriques AC; Paczek L; Chapman J; Burke JT;
    Transplantation; 2003 Jul; 76(2):364-70. PubMed ID: 12883194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal graft survival in patients with systemic lupus erythematosus].
    Chew-Wong A; Soltero L; Diná E; Alvarez-Sandoval E; Alberú J; Gamba G; Correa-Rotter R
    Rev Invest Clin; 2002; 54(1):21-8. PubMed ID: 11995403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of early biopsy on the outcome of kidney transplantation.
    Dominguez J; Kompatzki A; Norambuena R; Arenas J; Dell'Oro A; Bustamante A; Pinochet R; Cabello JM; Alvarez S; Pais E; Llanos R; Cortes-Monroy G
    Transplant Proc; 2005 Oct; 37(8):3361-3. PubMed ID: 16298596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity.
    Holzmacher R; Kendziorski C; Michael Hofman R; Jaffery J; Becker B; Djamali A
    Nephrol Dial Transplant; 2005 Jul; 20(7):1456-62. PubMed ID: 15840674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
    Joss N; Rodger RS; McMillan MA; Junor BJ
    Transplantation; 2007 Mar; 83(5):582-7. PubMed ID: 17353778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.